Meeting
2023 ASCO Annual Meeting
A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable colorectal cancer.
Authors
Julie L. Koenig
Harvard Radiation Oncology Program, Boston, MA
Julie L. Koenig , Leon Pappas , Beow Y. Yeap , Jeffrey William Clark , Samuel J Klempner , David P. Ryan , Jill N. Allen , Lawrence Scott Blaszkowsky , Bruce J. Giantonio , Kimberly Perez , Benjamin L. Schlechter , Jennifer Yon-Li Wo , Hannah Johnson Roberts , Jeffrey A. Meyerhardt , Sydney D. Ludes , Katharine Zecca , Lorraine C. Drapek , Arnav Mehta , Theodore S. Hong , Aparna Raj Parikh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Clinical Trial Registration Number
NCT04361162
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3584)
DOI
10.1200/JCO.2023.41.16_suppl.3584
Abstract #
3584
Poster Bd #
284
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable pancreatic adenocarcinoma.
First Author: Julie L. Koenig
Poster
2019 ASCO Annual Meeting
A phase II study of ipilimumab and nivolumab with radiation in microsatellite stable (MSS) metastatic colorectal adenocarcinoma (mCRC).
First Author: Aparna Raj Parikh
Poster
2023 ASCO Annual Meeting
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort.
First Author: Lorenzo Pilla
Poster
2019 Gastrointestinal Cancers Symposium
A phase II study of ipilimumab and nivolumab with radiation in metastatic pancreatic adenocarcinoma.
First Author: Aparna Parikh